Isbn: 9781441925374 - targeted therapies in cancer:: myth or reality? (advances in experimental medicine and biology, band 610) (3 Ergebnisse)

Targeted Therapies in Cancer:: Myth or Reality? (Advances in Experimental Medicine and Biology, 610)
Sprache: Englisch
Verlag: Springer, 2010
Serie: Buch 35 von 544 - Advances in Experimental Medicine and Biology
- Softcover
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 177,87
EUR 10,93 VersandVersand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
Zustand: New. In English.

Sprache: Englisch
Verlag: Springer, 2007
Serie: Buch 35 von 544 - Advances in Experimental Medicine and Biology
- Softcover
Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 234,63
EUR 11,66 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
Paperback. Zustand: Brand New. 200 pages. 9.00x6.00x0.46 inches. In Stock.

Sprache: Englisch
Verlag: Springer, 2010
Serie: Buch 35 von 544 - Advances in Experimental Medicine and Biology
- Softcover
Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 223,07
EUR 30,50 VersandVersand von Deutschland nach USAAnzahl: 1 verfügbar
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - In September 2005 an International Meeting on 'Targeted Therapies in Cancer: Myth or Reality' was held in Milan. This successful Meeting was intended to represent a forum for scientists and clinicians working in cancer drug discovery and therapy to share their reflections and experiences on how the paradigm shift from empiricism to molecular targeted therapies is contributing to the translation of basic knowledge into new therapies for cancer patients. This book collects the contributions given by scientists and clinicians, from Academia and Industry, who participated to this Meeting.We hope that this book contributes to improve our approach to cancer drug discovery and, ultimately, to find new, more efficacious and better tolerated drugs for cancer patients. It provides an overview of diverse approaches ranging from drug discovery to cellular therapy. Although this change in paradigm has been useful, its entry into the clinical arena was associates with unforeseen problems including the emergence of resistance, unexpected side effects and failures. Time is therefore ripe for a critical cultural reflection on the state of the art, prospects and limitations. Ultimately, is targeted therapy in cancer a myth or a reality.…